NCT07673887 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT07673887
Title	A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Astellas Pharma Global Development, Inc.
Indications	gastroesophageal junction adenocarcinoma gastric adenocarcinoma
Therapies	Fluorouracil + Leucovorin + Oxaliplatin ASP2138 + Capecitabine + Oxaliplatin + Pembrolizumab Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab Capecitabine + Oxaliplatin Capecitabine + Oxaliplatin + Pembrolizumab ASP2138 + Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA

Additional content available in CKB BOOST